Osteoporosis post-menopausal and Atherosclerosis

Summary:

Atherosclerosis is found among people with Osteoporosis post-menopausal, especially for people who are female, 60+ old.

The study analyzes which people have Atherosclerosis with Osteoporosis post-menopausal. It is created by eHealthMe based on reports of 32 people who have Osteoporosis post-menopausal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteoporosis post-menopausal?

Osteoporosis post-menopausal (weak bone with possibility to break after stopped menstrual cycles) is found to be associated with 41 drugs and 110 conditions by eHealthMe. Check the latest studies of Osteoporosis post-menopausal.

What is Atherosclerosis?

Atherosclerosis (disorder of the arteries) is found to be associated with 1,203 drugs and 1,533 conditions by eHealthMe. Check the latest studies of Atherosclerosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

32 people who have Osteoporosis Post-Menopausal and Atherosclerosis are studied.

Would you have Atherosclerosis when you have Osteoporosis post-menopausal?

Gender of people who have Osteoporosis Post-Menopausal and experienced Atherosclerosis *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Osteoporosis Post-Menopausal and experienced Atherosclerosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 3.23 %
  • 60+: 96.77 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 21.88%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
  3. Headache (pain in head): 3 people, 9.38%
  4. Pain: 2 people, 6.25%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 6.25%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.25%
  7. Type 2 Diabetes: 1 person, 3.12%
  8. Constipation: 1 person, 3.12%
  9. Dementia (madness): 1 person, 3.12%
  10. Depression: 1 person, 3.12%

Common drugs taken by these people *:

  1. Prolia: 17 people, 53.12%
  2. Calcium: 7 people, 21.88%
  3. Advil Liqui-Gels: 3 people, 9.38%
  4. Lisinopril: 3 people, 9.38%
  5. Lexapro: 2 people, 6.25%
  6. Namenda: 2 people, 6.25%
  7. Morphine: 2 people, 6.25%
  8. Coreg: 2 people, 6.25%
  9. Denavir: 2 people, 6.25%
  10. Protonix: 2 people, 6.25%

Common symptoms for these people *:

  1. Chest Pain: 6 people, 18.75%
  2. Back Pain: 6 people, 18.75%
  3. Fall: 5 people, 15.62%
  4. Acute Kidney Failure: 5 people, 15.62%
  5. Pneumonia: 4 people, 12.50%
  6. Renal Cyst (kidney cyst): 4 people, 12.50%
  7. Dyspnea (difficult or laboured breathing): 4 people, 12.50%
  8. Renal Artery Stenosis (narrowing of renal artery): 3 people, 9.38%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 9.38%
  10. Creatinine Renal Clearance Decreased: 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atherosclerosis?

- Check whether Atherosclerosis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Atherosclerosis:

All the conditions that are associated with Atherosclerosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atherosclerosis and Osteoporosis post-menopausal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: